̽��ֱ��

Why do some people with mental illnesses entertain bizarre and seemingly irrational beliefs that make their lives a misery?

̽��ֱ��commonly held assumption that as primates evolved, their brains always tended to get bigger has been challenged by a team of scientists at Cambridge and Durham.

Cambridge scientists are asking what role stem cells play in how cancer develops, spreads and relapses.

For some children, acquiring the important skills of learning to read or do arithmetic is fraught with difficulty. Educational neuroscience is helping to understand why.

̽��ֱ��path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.

A new European research consortium, in which Cambridge will play a major role, is to receive 3 million Euros to conduct research into the escalating epidemic of obesity. ̽��ֱ��'EurOCHIP’ project brings together a group of leading European experts to investigate how signals from the gut communicate with the brain to control appetite.

There has been speculation for many years that the human brain lives “on the edge of chaos”, at a critical transition point between randomness and order; but direct experimental evidence has been lacking.

Exposure to second-hand smoke could increase the risk of developing dementia and other forms of cognitive impairment, according to research published by Dr David Llewellyn from the ̽��ֱ�� of Cambridge and his collaborators.

Scientists have uncovered the underlying biological reason why locusts form migrating swarms. Their findings, reported in today's edition of Science, could be used in the future to prevent the plagues which devastate crops (notably in developing countries), affecting the livelihood of one in ten people across the globe.

Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis.